Conditions: Seasonal Allergic Rhinitis (SAR)
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 1176
Healthy volunteers: no

Brief summary:
Study to evaluate the efficacy, safety and tolerability of GSP 301 NS compared with placebo NS and individual monotherapy formulations for the treatment of Seasonal Allergic Rhinitis (subjects 12 years of age and older)

Detailed description:

Arms:
arm 1: None arm 2: None arm 3: None arm 4: None

Interventions: intervention 1: GSP 301 NS intervention 2: GOM-NS intervention 3: GMM-2 NS intervention 4: GSP 301 placebo NS
Intervention descriptions: intervention 1: 2 spray in each nostril twice daily for 14 days intervention 2: 2 spray in each nostril twice daily for 14 days intervention 3: 2 spray in each nostril twice daily for 14 days intervention 4: 2 spray in each nostril twice daily for 14 days

Protocol document: